Adaptive Biotechnologies Corporation
ADPT
$7.10
-$0.3081-4.16%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.10% | -1.34% | -10.99% | -5.33% | -8.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.10% | -1.34% | -10.99% | -5.33% | -8.11% |
| Cost of Revenue | -1.92% | -65.19% | -61.66% | -66.82% | -65.29% |
| Gross Profit | 9.92% | 1,171.52% | 520.49% | 794.28% | 803.24% |
| SG&A Expenses | -8.66% | -8.78% | -8.10% | -3.24% | -6.31% |
| Depreciation & Amortization | 0.24% | 0.29% | 0.29% | 0.24% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.11% | -8.11% | -6.59% | -2.90% | -3.53% |
| Operating Income | 22.95% | 14.35% | 2.19% | 0.59% | -0.71% |
| Income Before Tax | 29.16% | 0.34% | -11.82% | -10.17% | -12.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.16% | 0.34% | -11.82% | -10.17% | -12.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 90.74% | 50.72% | 28.40% | -33.05% | -69.49% |
| Net Income | 29.19% | 0.36% | -11.81% | -10.20% | -12.52% |
| EBIT | 22.95% | 14.35% | 2.19% | 0.59% | -0.71% |
| EBITDA | 24.13% | 15.07% | 2.25% | 1.08% | -0.06% |
| EPS Basic | 30.45% | 1.85% | -10.21% | -8.70% | -10.98% |
| Normalized Basic EPS | 24.87% | 16.66% | 5.10% | 2.66% | -0.67% |
| EPS Diluted | 30.45% | 1.85% | -10.21% | -8.35% | -10.64% |
| Normalized Diluted EPS | 24.87% | 16.66% | 5.10% | 2.66% | -0.67% |
| Average Basic Shares Outstanding | 1.88% | 1.73% | 1.55% | 1.39% | 1.31% |
| Average Diluted Shares Outstanding | 1.88% | 1.73% | 1.55% | 1.39% | 1.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
